Vyant Bio, Inc.
VYNT · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10 | $21 | $1 | $4 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $2 | $0 | $3 |
| Total Curr. Assets | $12 | $23 | $2 | $7 |
| Property Plant & Equip (Net) | $3 | $2 | $2 | $1 |
| Goodwill | $0 | $0 | $3 | $3 |
| Intangibles | $0 | $0 | $0 | $3 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $13 | -$3 | $1 |
| Total NC Assets | $4 | $14 | $2 | $8 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $15 | $38 | $4 | $15 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $0 |
| Short-Term Debt | $1 | $0 | $0 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $1 |
| Other Curr. Liab. | $2 | $4 | $0 | $4 |
| Total Curr. Liab. | $4 | $5 | $2 | $7 |
| LT Debt | $2 | $1 | $7 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $31 | $0 |
| Total NC Liab. | $2 | $1 | $38 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $5 | $6 | $40 | $8 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $29 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$102 | -$79 | -$38 | -$164 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $111 | $110 | -$28 | $7 |
| Total Equity | $10 | $31 | -$36 | $7 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $15 | $38 | $4 | $15 |
| Net Debt | -$8 | -$19 | $7 | -$2 |